Magenta Therapeutics Reports Second Quarter 2019 Financial Results and Recent Business Highlights

Magenta Therapeutics Reports Second Quarter 2019 Financial Results and Recent Business Highlights

5 years ago
Anonymous $ZuTig1gZkQ

https://www.businesswire.com/news/home/20190808005189/en/

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Aug 8, 2019--

Magenta Therapeutics (NASDAQ: MGTA), a clinical-stage biotechnology company developing novel medicines to bring the curative power of stem cell transplant to more patients, today reported financial results for the second quarter ended June 30, 2019 and recent business highlights.